Related Experiment Videos
Tryptophan metabolism and oxidative stress in patients with Huntington's disease.
N Stoy1, G M Mackay, C M Forrest
1Royal Hospital for Neuro-Disability, Putney, London, UK.
Journal of Neurochemistry
|April 20, 2005
Summary
Huntington's disease (HD) patients show altered tryptophan metabolism and increased oxidative stress, suggesting these factors contribute to brain dysfunction. This study investigated kynurenine pathway metabolites in HD, revealing key metabolic and inflammatory differences.
Area of Science:
- Neuroscience
- Biochemistry
- Metabolic Disorders
Background:
- The kynurenine pathway (KP) is implicated in neurodegenerative diseases.
- Huntington's disease (HD) is a progressive neurodegenerative disorder with poorly understood mechanisms.
Purpose of the Study:
- To investigate alterations in KP metabolites, inflammation, and oxidative stress in HD patients.
- To explore the relationship between tryptophan metabolism and disease progression in HD.
Main Methods:
- Tryptophan depletion and loading tests were performed on HD patients and healthy controls.
- Blood samples were analyzed for KP metabolites, C-reactive protein, neopterin, and lipid peroxidation products.
Main Results:
- HD patients exhibited an increased kynurenine:tryptophan ratio, indicating higher indoleamine dioxygenase activity.
- Elevated markers of inflammation (C-reactive protein, neopterin) and oxidative stress (lipid peroxidation) were observed in HD patients.
- Kynurenine aminotransferase activity appeared lower in HD patients, with no compensatory increase in kynurenic acid.
Conclusions:
- HD patients display abnormal tryptophan metabolism and heightened oxidative stress.
- These metabolic and oxidative abnormalities may contribute to the ongoing brain dysfunction observed in Huntington's disease.